Oruka Therapeutics, Inc.
ORKA
Kedudukan dalam Saham
#3289
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Harga Saham
$81.40
Modal Pasaran
$5.39B
Perubahan (1 hari)
1.86%
Perubahan (1 tahun)
205.46%
Negara
US
Perdagangan Oruka Therapeutics, Inc. (ORKA)
Kategori
Healthcare
Bilangan saham terbitan bagi Oruka Therapeutics, Inc. (ORKA)
Bilangan saham terbitan setakat October 2026: 0
Menurut laporan kewangan terkini dan harga saham Oruka Therapeutics, Inc., bilangan saham terbitan semasa ialah 0. Pada akhir October 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Oruka Therapeutics, Inc. (ORKA) dari 2005 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2025 | 45.61M | 171.68% |
| 2024 | 16.79M | 16.46% |
| 2023 | 14.42M | 0.04% |
| 2022 | 14.41M | 3.64% |
| 2021 | 13.90M | 195.18% |
| 2020 | 4.71M | 4,178.07% |
| 2019 | 110.10K | 71.73% |
| 2018 | 64.12K | 32.76% |
| 2017 | 48.29K | 15.04% |
| 2016 | 41.98K | 44.17% |
| 2015 | 29.12K | 114.74% |
| 2014 | 13.56K | 137.59% |
| 2013 | 5.71K | 288.23% |
| 2012 | 1.47K | 32.91% |
| 2011 | 1.11K | 17.91% |
| 2010 | 938.00 | 19.95% |
| 2009 | 782.00 | 18,629.19% |
| 2008 | 4.18 | -98.58% |
| 2007 | 294.00 | 3.52% |
| 2006 | 284.00 | 24.56% |
| 2005 | 228.00 | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| 0.00 | - |
BE
|
